Earlier this month, the FDA released programmatic guidance intended to clarify the current review practices for the Humanitarian Device Exemption (“HDE”) Program (“Guidance”) reflecting recent changes in the HDE Program resulting from statutory amendments made by the 21st Century Cures. The Guidance addresses frequently asked questions about FDA actions on HDE applications, post-approval requirements, and includes a filing checklist to clarify the required information for the FDA to consider whether an HDE application is ready for substantive review.
Unlike ...
Blog Editors
Recent Updates
- The DOJ’s Bulk Sensitive Data Rule and Your Obligation to “Know Your Reporting Requirements”
- Is Your Product Ready to Be Listed? What the Dietary Supplement Listing Act of 2026 Means for Your Business
- New York’s Food Safety and Chemical Disclosure Act: A State-Level Overhaul of GRAS Regulation
- Fighting Fire with Fire: Project Glasswing and AI-Powered Cyber Defense in Health Care, Financial Health and Other Critical Infrastructure
- Microsoft Copilot Health: Another Player In AI-Driven Healthcare